<DOC>
	<DOCNO>NCT02835664</DOCNO>
	<brief_summary>This study investigate effect 6 week Nicotinamide Riboside supplementation ( 1000 mg/day ) metabolic health healthy ( pre ) obese human . The primary objective hepatic whole body insulin sensitivity . Secondary objective , provide information underlie mechanism , muscle mitochondrial function , brown fat activity , ectopic lipid accumulation , energy metabolism , cardiovascular risk parameter , body composition acetylcarnitine level .</brief_summary>
	<brief_title>Nicotinamide Riboside Metabolic Health</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Signed informed consent Caucasian Males postmenopausal female Aged 4565 year start study Body mass index ( BMI ) 27 35 kg/m2 Stable dietary habit ( weight loss gain &gt; 5kg past 3 month ) Sedentary lifestyle ( 2 hour sport per week ) Type 2 diabetes Active disease ( cardiovascular , diabetes , liver , kidney , cancer ) Contraindication MRI Participation earlier research medical examination include PET/CT scan Alcohol consumption &gt; 2 serving per day Smoking past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Nicotinamide Riboside</keyword>
	<keyword>Obesity</keyword>
	<keyword>Metabolic health</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Mitochondrial function</keyword>
	<keyword>Brown adipose tissue</keyword>
	<keyword>Energy expenditure</keyword>
	<keyword>Ectopic lipid accumulation</keyword>
	<keyword>Cardiovascular risk</keyword>
	<keyword>Acetylcarnitine</keyword>
</DOC>